| US12049471B2 | 30 July 2024 | Grant | US18068195 | Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof | Nurix Therapeutics Inc |
|---|
| US12016860B2 | 25 June 2024 | Grant | US17716982 | Combination therapies with cbl-b inhibitor compounds | Nurix Therapeutics Inc |
|---|
| US11976071B2 | 7 May 2024 | Grant | US2022038135W | Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associated kinases | Nurix Therapeutics Inc; Gilead Sciences Inc |
|---|
| US11951133B2 | 9 April 2024 | Grant | US17864307 | 3-substituted piperidine compounds for cbl-b inhibition, and use thereof | Nurix Therapeutics Inc |
|---|
| US11866442B2 | 9 January 2024 | Grant | US17876433 | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway | Nurix Therapeutics Inc |
|---|